NEXI News and Press, NexImmune Inc.

Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...

Revenues at € 781.6 million in 1Q24, +6.0% Y/Y EBITDA at € 361.7 million in 1Q24, +8.6% Y/Y, with c. +112 bps EBITDA margin expansion 2024 Guidance confirmed Up to € 500 million share buy-back program launched today Th...

Rome becomes the first European city to offer open loop transit payments to JCB Cardmembers TOKYO & LONDON, May 8, 2024 - (JCN Newswire) - Boarding public transport and pay the fare by simply tapping with a contactless payment card on turnstiles or authorized readers: Rome is th...

2024-04-05 14:55:10 ET More on mid-day movers & stock 22nd Century Group, Inc. (XXII) Q4 2023 Earnings Call Transcript Grindrod Shipping: Favorable Outlook, M&A Completion, And Very Cheap Grindrod Shipping: When A Young Fleet And Healthy Financials Are Not En...

Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...

2024-03-07 09:09:27 ET CERo Therapeutics ( CERO ) +625% after announces publication of preclinical research supporting the use of its clinical candidate CER-1236 to treat AML patients . Lytus Technologies ( LYT ) +210% after enters $326 billion data center market...

2023 guidance delivered Revenues at € 3,361.7 million in FY23, +7.0% Y/Y EBITDA at € 1,751.8 million in FY23, +10.0% Y/Y, with c. +146 bps EBITDA margin expansion Strong Excess cash generation growth, at more than € 600 million in F...

GAITHERSBURG, Md., Feb. 06, 2024 (GLOBE NEWSWIRE) -- NexImmune, Inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells in oncology, autoimmune and infectious diseases, today...

2024-02-05 08:25:25 ET More on pre-market losers & stocks. Livent: Undervalued With Significant Upside Potential Livent: Wonderful Company Fairly Valued Livent And Albemarle: 2 Lithium Stocks To Buy Now Livent and Allkem shareholders approve merger of equ...

2024-02-02 14:54:54 ET More on Neximmune Financial information for Neximmune Read the full article on Seeking Alpha For further details see: NexImmune slips after securities offering